HER2 mutation generally accompanied a higher TMB than HER2 wild-type in various tumors, except kidney renal papillary cell carcinoma, lung squamous cell carcinoma (LUSC), and uterine carcinosarcoma (UCS) (Supplementary Figure S2). The gene discussed is ERBB2; the disease is uterine carcinosarcoma.